MKS Inc. $MKSI Shares Purchased by Harvey Partners LLC

Harvey Partners LLC grew its holdings in shares of MKS Inc. (NASDAQ:MKSI) by 3.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 269,599 shares of the scientific and technical instruments company’s stock after acquiring an additional 8,599 shares during the period. MKS comprises about 2.6% of Harvey Partners LLC’s investment portfolio, making the stock its 15th biggest holding. Harvey Partners LLC owned approximately 0.40% of MKS worth $26,787,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of MKSI. Wellington Management Group LLP increased its stake in MKS by 41.8% during the first quarter. Wellington Management Group LLP now owns 3,250,085 shares of the scientific and technical instruments company’s stock valued at $260,494,000 after purchasing an additional 958,607 shares during the last quarter. Norges Bank bought a new stake in shares of MKS during the 2nd quarter valued at about $85,391,000. Leith Wheeler Investment Counsel Ltd. grew its position in shares of MKS by 843.4% during the 2nd quarter. Leith Wheeler Investment Counsel Ltd. now owns 690,287 shares of the scientific and technical instruments company’s stock valued at $68,587,000 after buying an additional 617,113 shares during the last quarter. Channing Capital Management LLC acquired a new stake in MKS during the first quarter worth about $44,320,000. Finally, Frontier Capital Management Co. LLC lifted its holdings in MKS by 146.4% in the second quarter. Frontier Capital Management Co. LLC now owns 912,380 shares of the scientific and technical instruments company’s stock worth $90,654,000 after acquiring an additional 542,094 shares during the last quarter. 99.79% of the stock is owned by hedge funds and other institutional investors.

MKS Price Performance

Shares of NASDAQ MKSI opened at $155.77 on Friday. The stock has a market cap of $10.46 billion, a P/E ratio of 37.81, a P/E/G ratio of 1.79 and a beta of 1.93. The firm’s 50-day simple moving average is $146.49 and its 200 day simple moving average is $118.36. MKS Inc. has a fifty-two week low of $54.84 and a fifty-two week high of $170.37. The company has a quick ratio of 1.81, a current ratio of 2.86 and a debt-to-equity ratio of 1.64.

MKS (NASDAQ:MKSI) last released its earnings results on Wednesday, November 5th. The scientific and technical instruments company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.80 by $0.13. The firm had revenue of $988.00 million for the quarter, compared to analysts’ expectations of $963.87 million. MKS had a net margin of 7.25% and a return on equity of 20.80%. MKS’s quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter last year, the company earned $1.72 EPS. MKS has set its Q4 2025 guidance at 1.930-2.610 EPS. Equities analysts expect that MKS Inc. will post 6.94 EPS for the current year.

MKS Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 5th. Shareholders of record on Monday, November 24th were given a $0.22 dividend. This represents a $0.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date was Monday, November 24th. MKS’s dividend payout ratio is 21.36%.

Insider Buying and Selling at MKS

In other news, Director Elizabeth Mora sold 300 shares of the company’s stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $158.81, for a total value of $47,643.00. Following the completion of the sale, the director owned 18,963 shares in the company, valued at $3,011,514.03. This represents a 1.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Jacqueline F. Moloney sold 300 shares of the firm’s stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $122.14, for a total value of $36,642.00. Following the transaction, the director directly owned 11,562 shares of the company’s stock, valued at $1,412,182.68. This represents a 2.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 5,600 shares of company stock valued at $734,285. 0.57% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Mizuho set a $175.00 target price on MKS in a report on Thursday, November 6th. The Goldman Sachs Group boosted their price objective on MKS from $92.00 to $125.00 and gave the company a “sell” rating in a research report on Thursday, October 9th. Morgan Stanley reaffirmed an “overweight” rating and issued a $151.00 target price on shares of MKS in a research report on Monday, October 13th. Weiss Ratings reiterated a “hold (c)” rating on shares of MKS in a research note on Wednesday, October 8th. Finally, Wells Fargo & Company upped their price target on shares of MKS from $135.00 to $150.00 and gave the stock an “equal weight” rating in a research report on Friday, November 7th. Eight research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $161.10.

MKS Profile

MKS Instruments, Inc provides foundational technology solutions to semiconductor manufacturing, electronics and packaging, and specialty industrial applications in the United States, Germany, China, South Korea, and internationally. It operates through Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Material Solutions Division (MSD) segments.